Back to Quality Research
CTVACorteva Inc
Materials · Fertilizers & Agricultural Chemicals · Large
$12.45−3.19%
As of 23 Oct 2026Mkt cap $60.0B
Stage 13
AVOID
Fundamentals
57.5/75
Technical
3.0/15
Independent
60.5/90
GCAE viewstructural technical damage is a hard non-actionable condition
Price
- 1M
- −84.3%
- 3M
- −85.8%
- 6M
- −84.4%
- 1Y
- −80.3%
Financials & valuation
Cached filing evidence · as of 2026-10-02
Valuation
- P/E
- 8.2xHist median 43.8x
- Forward P/E
- —No validated forward-estimate source
- Price / FCF
- 13.5x
- FCF yield
- 7.4%
Quality
- ROIC
- 10.5%
- Operating margin
- 16.4%
- FCF margin
- 16.2%
- Current ratio
- 1.4x
Growth
- Revenue growth
- +2.9%Latest FY YoY
- Revenue CAGR
- +2.7%
- EPS CAGR
- −9.4%
- FCF CAGR
- +6.9%
Capital
- Share-count trend
- −2.2%3Y annualised
- Net cash
- $2.8B-0.8x OCF
Annual trend
- CAGR 2021–2025
- +2.7%
- Latest · 2025
- $17B
- YoY
- +2.9%
GCAE Research
- Quality Research
- PRE-AI
- Acceleration Radar
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
- Final / Opportunity
- UNRESEARCHED · NEW RESEARCH
Key takeaway
Awaiting four-lens research.
Unresolved question
Which timing read is better supported as new price and operating evidence arrives: production v2 or research v3?
Watch next
- Next earnings · 2026-11-11
- New current Route A/Route B candidate has no completed four-lens research.
More details & evidence
Production decision
- Stage 13
- AVOID
- Technical state
- damaged
- Rotation
- headwind
- Evidence
- fresh
Presentation freshness
- Stage 11 market
- 2026-10-23 · Massive
- Financial cache
- 2026-10-02
- Quality Research
- CURRENT
- THE ONE
- NOT FLAGGED
Authority
- Company page
- Presentation only
- Scores
- Frozen GCAE production outputs
- Research
- Research-only lanes; no score override
- Private portfolio
- Not loaded